Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
about
Respiratory viruses other than influenza virus: impact and therapeutic advancesParainfluenza virusesInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadRespiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsFourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveHow I treat influenza in patients with hematologic malignancies.Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsRespiratory syncytial virus infection in adultsEpidemiology and management of infections after lung transplantation.Community respiratory virus infections following lung transplantation.Prevention and treatment of viral infections in stem cell transplant recipients.Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function.Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.Respiratory viral infections after hematopoietic stem cell transplantation in children.The challenge of respiratory virus infections in hematopoietic cell transplant recipients.Viral infections in lung transplant recipients.Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcomeViral infections in immunocompromised patients.Lung transplant infection.Current management of parainfluenza pneumonitis in immunocompromised patients: a review.Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.The epidemiology of parainfluenza virus infection in lung transplant recipients.Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Parainfluenza virus type 3 infections in a hematology unit.Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell TransplantationThe burden of influenza B: a structured literature review
P2860
Q24655957-EB4FB75C-A2D7-4B4F-A475-66382FC6404FQ24682952-D698F101-C35B-4344-917E-5C1EEC7BA4DCQ26822988-3AA9D2BA-74F8-497B-9845-52E3D4ACF08BQ26829188-720689E6-D3E6-4CFF-B632-A36F8CB10D7CQ27021622-FE43D662-961E-4F21-9829-FBCD7AA6A94AQ28388806-92573386-6472-4F38-9A00-8D2129C3FA62Q30383456-E5FC5D8D-C2B1-4E36-A0DC-01D5D11CAF4EQ33714717-CBAA1A24-8C8E-4390-815F-95EACA5C6379Q33961877-6C4C94B3-5DCD-4F69-A728-247160B6D910Q34271709-95951A3D-A583-4D0C-A8DD-F2496D549BB4Q34330068-C734B6DC-673F-472E-ADAF-F76784630EFAQ34722706-3EBC3574-55E3-4192-9108-6754BE558C27Q35072098-EDE9CB79-786A-4C21-8F89-754504A63454Q36090174-71DDAFD8-E8FC-41E8-8A9B-8E1D96AD12FDQ36536329-A5C129D8-1657-4CBB-B39F-A8D6D8FB5264Q37266577-B4E7FB16-17C4-4B81-8DE0-B40B6D94C7ACQ37721885-96FB59A0-B515-4254-B2EF-3ED2C343C71EQ37726073-145E8135-F422-4FA5-B76C-C984B449E95FQ37824989-2BB48A4D-5594-4A44-ACE0-0A7BBBD8CF51Q38010486-C596D54A-955D-4C01-96BF-1BC870CD39ADQ38034753-54A75D48-3744-4BCF-B1B3-E5C11D857827Q39973043-301B3107-4C75-4739-87BF-975DA9885CF2Q40055495-D99FA5F6-DF0B-4B39-B795-27B002634502Q40721939-D41BF0BF-BAEF-4180-A3DA-9930F01A0A91Q42262215-4E8A46DC-698E-406C-B12D-2B9C20712246Q42279293-50961B75-6F70-4E0F-8F4C-ED754F51DECDQ42325543-5B14BA04-89BE-4590-85B5-D595DDCE7C42Q43848095-0372FE32-BDE8-4D11-891A-D8F2797F45E8Q44148387-2ACAFFD7-EFBF-4E8B-8A41-A8C54331C688Q44923546-A21E0AC9-7F56-4AEB-8E55-027701814C38Q45070426-840FA903-CBD8-40A5-9B03-BD2C5356AF04Q45370052-A2A093D3-16C5-4EA2-93B0-2CE8F7C165B4Q45734850-2EEEEA7A-F782-446B-8F94-EA7852BECC51Q45735386-CD6084AE-FAA4-4E50-8719-F4B7CF3F3A27Q45737985-21CA8608-498A-4970-A576-CA0D0907474EQ50550990-79F83E2D-43DE-438E-AD47-DA4E3D4C9FE4Q57053316-242102EF-D322-47A1-81D1-6BC2590832DFQ57943670-617BD697-DF00-4383-81A1-554CEA54A828
P2860
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Ribavirin therapy in bone marr ...... respiratory tract infections.
@en
Ribavirin therapy in bone marr ...... respiratory tract infections.
@nl
type
label
Ribavirin therapy in bone marr ...... respiratory tract infections.
@en
Ribavirin therapy in bone marr ...... respiratory tract infections.
@nl
prefLabel
Ribavirin therapy in bone marr ...... respiratory tract infections.
@en
Ribavirin therapy in bone marr ...... respiratory tract infections.
@nl
P2093
P356
P1476
Ribavirin therapy in bone marr ...... respiratory tract infections.
@en
P2093
Andersson J
Ekelöf-Andström E
Sparrelid E
Winiarski J
P2888
P304
P356
10.1038/SJ.BMT.1700752
P407
P50
P577
1997-05-01T00:00:00Z